embelin has been researched along with Benign Neoplasms in 8 studies
embelin: from Embelia fruit (Myrsinaceae)
embelin : A member of the class of dihydroxy-1,4-benzoquinones that is 2,5-dihydroxy-1,4-benzoquinone which is substituted by an undecyl group at position 3. Isolated from Lysimachia punctata and Embelia ribes, it exhibits antimicrobial, antineoplastic and inhibitory activity towards hepatitis C protease.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Chronic diseases are a serious health concern worldwide, especially in the elderly population." | 6.82 | Embelin: A novel XIAP inhibitor for the prevention and treatment of chronic diseases. ( Devi Daimary, U; Girisa, S; Kumar, A; Kunnumakkara, AB; Parama, D; Verma, E, 2022) |
| "Embelin is an active component extracted from the fruits of Embelia ribes." | 6.53 | Embelin and Its Role in Chronic Diseases. ( Lu, H; Qiao, L; Wang, J; Wang, Y; Zhou, Y, 2016) |
| "Chronic diseases are a serious health concern worldwide, especially in the elderly population." | 2.82 | Embelin: A novel XIAP inhibitor for the prevention and treatment of chronic diseases. ( Devi Daimary, U; Girisa, S; Kumar, A; Kunnumakkara, AB; Parama, D; Verma, E, 2022) |
| "Embelin is a naturally-occurring benzoquinone compound that has been shown to possess many biological properties relevant to human cancer prevention and treatment, and increasing evidence indicates that embelin may modulate various characteristic hallmarks of tumor cells." | 2.58 | The Application of Embelin for Cancer Prevention and Therapy. ( Ahn, KS; Ko, JH; Lee, SG; Mishra, S; Sethi, G; Shanmugam, MK; Um, JY; Yang, WM, 2018) |
| "Embelin is an active component extracted from the fruits of Embelia ribes." | 2.53 | Embelin and Its Role in Chronic Diseases. ( Lu, H; Qiao, L; Wang, J; Wang, Y; Zhou, Y, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (87.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, R | 1 |
| Elf, S | 1 |
| Shan, C | 1 |
| Kang, HB | 1 |
| Ji, Q | 1 |
| Zhou, L | 1 |
| Hitosugi, T | 1 |
| Zhang, L | 1 |
| Zhang, S | 1 |
| Seo, JH | 1 |
| Xie, J | 1 |
| Tucker, M | 1 |
| Gu, TL | 1 |
| Sudderth, J | 1 |
| Jiang, L | 1 |
| Mitsche, M | 1 |
| DeBerardinis, RJ | 1 |
| Wu, S | 1 |
| Li, Y | 1 |
| Mao, H | 1 |
| Chen, PR | 1 |
| Wang, D | 1 |
| Chen, GZ | 1 |
| Hurwitz, SJ | 1 |
| Lonial, S | 1 |
| Arellano, ML | 1 |
| Khoury, HJ | 1 |
| Khuri, FR | 1 |
| Lee, BH | 1 |
| Lei, Q | 1 |
| Brat, DJ | 1 |
| Ye, K | 1 |
| Boggon, TJ | 1 |
| He, C | 1 |
| Kang, S | 1 |
| Fan, J | 1 |
| Chen, J | 1 |
| Devi Daimary, U | 1 |
| Girisa, S | 1 |
| Parama, D | 1 |
| Verma, E | 1 |
| Kumar, A | 1 |
| Kunnumakkara, AB | 1 |
| Ko, JH | 1 |
| Lee, SG | 1 |
| Yang, WM | 1 |
| Um, JY | 1 |
| Sethi, G | 1 |
| Mishra, S | 1 |
| Shanmugam, MK | 1 |
| Ahn, KS | 1 |
| Prabhu, KS | 1 |
| Achkar, IW | 1 |
| Kuttikrishnan, S | 1 |
| Akhtar, S | 1 |
| Khan, AQ | 1 |
| Siveen, KS | 1 |
| Uddin, S | 1 |
| Avisetti, DR | 1 |
| Amireddy, N | 1 |
| Kalivendi, SV | 1 |
| Coutelle, O | 1 |
| Hornig-Do, HT | 1 |
| Witt, A | 1 |
| Andree, M | 1 |
| Schiffmann, LM | 1 |
| Piekarek, M | 1 |
| Brinkmann, K | 1 |
| Seeger, JM | 1 |
| Liwschitz, M | 1 |
| Miwa, S | 1 |
| Hallek, M | 1 |
| Krönke, M | 1 |
| Trifunovic, A | 1 |
| Eming, SA | 1 |
| Wiesner, RJ | 1 |
| Hacker, UT | 1 |
| Kashkar, H | 1 |
| Dhanjal, JK | 1 |
| Nigam, N | 1 |
| Sharma, S | 1 |
| Chaudhary, A | 1 |
| Kaul, SC | 1 |
| Grover, A | 1 |
| Wadhwa, R | 1 |
| Lu, H | 1 |
| Wang, J | 1 |
| Wang, Y | 1 |
| Qiao, L | 1 |
| Zhou, Y | 1 |
5 reviews available for embelin and Benign Neoplasms
| Article | Year |
|---|---|
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; | 2015 |
Embelin: A novel XIAP inhibitor for the prevention and treatment of chronic diseases.
Topics: Benzoquinones; Chronic Disease; Embelia; Heart Diseases; Humans; Neoplasms; Obesity; X-Linked Inhibi | 2022 |
The Application of Embelin for Cancer Prevention and Therapy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Autophagy; Benzoquinones; Biological Products; Drug Syner | 2018 |
Embelin: a benzoquinone possesses therapeutic potential for the treatment of human cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Benzoquinones; Cell Proliferation; Embelia; H | 2018 |
Embelin and Its Role in Chronic Diseases.
Topics: Animals; Anti-Infective Agents; Antineoplastic Agents, Phytogenic; Autoimmune Diseases; Benzoquinone | 2016 |
3 other studies available for embelin and Benign Neoplasms
| Article | Year |
|---|---|
The mitochondrial effects of embelin are independent of its MAP kinase regulation: Role of p53 in conferring selectivity towards cancer cells.
Topics: A549 Cells; Antineoplastic Agents; Apoptosis; Benzoquinones; Epithelial Cells; Humans; Neoplasms; p3 | 2019 |
Embelin inhibits endothelial mitochondrial respiration and impairs neoangiogenesis during tumor growth and wound healing.
Topics: Animals; Antineoplastic Agents; Benzoquinones; Cell Respiration; Disease Models, Animal; Endothelial | 2014 |
Embelin inhibits TNF-α converting enzyme and cancer cell metastasis: molecular dynamics and experimental evidence.
Topics: ADAM Proteins; ADAM17 Protein; Benzoquinones; Catalytic Domain; Cell Line, Tumor; Cell Movement; Cel | 2014 |